Strata Critical Medical (NASDAQ:SRTA) CAO Sells $59,637.00 in Stock

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 10,300 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00. Following the completion of the sale, the chief accounting officer owned 191,838 shares of the company’s stock, valued at approximately $1,110,742.02. This represents a 5.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25.

Strata Critical Medical Stock Performance

Shares of NASDAQ SRTA traded up $0.01 during trading hours on Tuesday, hitting $6.14. 981,609 shares of the stock were exchanged, compared to its average volume of 869,593. The firm has a market capitalization of $531.29 million, a P/E ratio of -76.75 and a beta of 2.15. The firm’s fifty day simple moving average is $4.82. Strata Critical Medical has a 12 month low of $3.40 and a 12 month high of $6.27.

Strata Critical Medical (NASDAQ:SRTA) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The business had revenue of $67.38 million for the quarter. Research analysts predict that Strata Critical Medical will post -0.14 EPS for the current year.

Wall Street Analyst Weigh In

SRTA has been the topic of a number of recent analyst reports. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Craig Hallum initiated coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. Finally, B. Riley Financial initiated coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Institutional Trading of Strata Critical Medical

Large investors have recently made changes to their positions in the business. Bank of America Corp DE boosted its holdings in shares of Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after acquiring an additional 25,379 shares during the last quarter. Quantinno Capital Management LP boosted its holdings in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after acquiring an additional 71,155 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after acquiring an additional 172,154 shares during the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical in the 1st quarter valued at $537,000. Finally, Seelaus Asset Management LLC boosted its holdings in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after acquiring an additional 6,000 shares during the last quarter. 47.36% of the stock is owned by hedge funds and other institutional investors.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.